Quantinno Capital Management LP Invests $647,000 in The Chemours Company (NYSE:CC)

Quantinno Capital Management LP purchased a new stake in The Chemours Company (NYSE:CC - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 38,311 shares of the specialty chemicals company's stock, valued at approximately $647,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Strategic Financial Concepts LLC bought a new stake in Chemours in the 4th quarter worth approximately $357,000. Entropy Technologies LP purchased a new position in shares of Chemours during the fourth quarter worth approximately $266,000. Sei Investments Co. boosted its position in Chemours by 779.5% during the fourth quarter. Sei Investments Co. now owns 174,555 shares of the specialty chemicals company's stock valued at $2,950,000 after buying an additional 154,709 shares during the period. Twelve Points Wealth Management LLC lifted its stake in shares of Chemours by 42.8% in the 4th quarter. Twelve Points Wealth Management LLC now owns 78,325 shares of the specialty chemicals company's stock valued at $1,324,000 after acquiring an additional 23,490 shares during the last quarter. Finally, KLP Kapitalforvaltning AS bought a new stake in Chemours in the fourth quarter valued at approximately $515,000. 76.26% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CFO Shane Hostetter acquired 4,450 shares of the stock in a transaction on Monday, May 19th. The stock was acquired at an average price of $11.28 per share, for a total transaction of $50,196.00. Following the completion of the purchase, the chief financial officer now owns 59,694 shares of the company's stock, valued at $673,348.32. This represents a 8.06% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.34% of the stock is currently owned by insiders.

Chemours Stock Up 0.6%

Shares of CC stock traded up $0.07 during midday trading on Friday, reaching $10.18. 574,455 shares of the stock were exchanged, compared to its average volume of 2,118,008. The firm has a market cap of $1.52 billion, a PE ratio of 17.83 and a beta of 1.76. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70. The company's 50 day moving average is $11.63 and its two-hundred day moving average is $15.74. The Chemours Company has a 1 year low of $9.33 and a 1 year high of $25.98.

Chemours (NYSE:CC - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.19 by ($0.06). The firm had revenue of $1.37 billion during the quarter, compared to the consensus estimate of $1.36 billion. Chemours had a return on equity of 26.54% and a net margin of 1.51%. Chemours's revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter last year, the company posted $0.32 EPS. On average, equities research analysts predict that The Chemours Company will post 2.03 EPS for the current year.

Chemours Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Monday, June 16th. Investors of record on Monday, May 19th will be paid a dividend of $0.0875 per share. This represents a yield of 3.17%. The ex-dividend date is Friday, May 16th. Chemours's payout ratio is currently 175.00%.

Analyst Ratings Changes

CC has been the topic of several analyst reports. Morgan Stanley decreased their target price on shares of Chemours from $22.00 to $15.00 and set an "equal weight" rating on the stock in a research note on Monday, May 12th. BMO Capital Markets lowered their price objective on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a research note on Wednesday, February 19th. The Goldman Sachs Group cut their target price on Chemours from $21.00 to $14.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 14th. Truist Financial reduced their price target on Chemours from $27.00 to $22.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Finally, Barclays dropped their price objective on Chemours from $16.00 to $13.00 and set an "equal weight" rating for the company in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $17.22.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.